Treace Medical Concepts (NASDAQ:TMCI) is gearing up to announce its quarterly earnings on Friday, 2026-02-27. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Treace Medical Concepts will report an earnings per share (EPS) of $-0.14.
Treace Medical Concepts bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Performance in Previous Earnings
Last quarter the company beat EPS by $0.01, which was followed by a 28.33% drop in the share price the next day.
Here’s a look at Treace Medical Concepts’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.29 | -0.30 | -0.04 |
| EPS Actual | -0.26 | -0.28 | -0.25 | -0.01 |
| Price Change % | -28.33 | 7.92 | -9.55 | -2.08 |
Market Performance of Treace Medical Concepts’s Stock
Shares of Treace Medical Concepts were trading at $2.04 as of February 25. Over the last 52-week period, shares …